Literature DB >> 3857961

Primary bone cancer incidence in black and white residents of New York State.

A P Polednak.   

Abstract

Some descriptive epidemiologic characteristics of primary bone cancers were presented for black and white residents of New York State (1975-1980) using data from the population-based New York State Cancer Registry. Average annual race- and age-specific incidence rates were calculated for 1975 to 1980 for three histologic types (i.e., osteosarcoma, Ewing's sarcoma, and chondrosarcoma). The significantly lower incidence of Ewing's sarcoma in blacks versus whites was confirmed, whereas lower rates for chondrosarcoma in blacks supported findings from the Surveillance, Epidemiology and End Results (SEER) Program. A higher rate of osteosarcoma in blacks versus whites in the less than 15-year age group, although not statistically significant, was consistent with findings from another population-based registry in the US. This difference was due to osteosarcoma of the leg, and could be related to racial differences in growth rates during childhood. Comparisons with data from Africa suggest certain similarities in patterns as well as some possible differences, which could provide general clues to etiology (i.e., genetic versus environmental factors).

Entities:  

Mesh:

Year:  1985        PMID: 3857961     DOI: 10.1002/1097-0142(19850615)55:12<2883::aid-cncr2820551231>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Malignant bone tumors in Kuwait: a 10-year clinicopathological study.

Authors:  K C Katchy; F Ziad; S Alexander; H Gad; M Abdel Mota'al
Journal:  Int Orthop       Date:  2005-09-29       Impact factor: 3.075

2.  Bone tumours in Cameroon: incidence, demography and histopathology.

Authors:  J Bahebeck; R Atangana; V Eyenga; A Pisoh; Z Sando; P Hoffmeyer
Journal:  Int Orthop       Date:  2003-08-26       Impact factor: 3.075

3.  Epidemiological characteristics of primary spinal osseous tumors in Eastern China.

Authors:  Zhenhua Zhou; Xudong Wang; Zhipeng Wu; Wending Huang; Jianru Xiao
Journal:  World J Surg Oncol       Date:  2017-04-04       Impact factor: 2.754

4.  Is There a Predisposition Gene for Ewing's Sarcoma?

Authors:  R L Randall; S L Lessnick; K B Jones; L G Gouw; J E Cummings; L Cannon-Albright; J D Schiffman
Journal:  J Oncol       Date:  2010-03-15       Impact factor: 4.375

5.  EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations.

Authors:  Robert Beck; Michael J Monument; W Scott Watkins; Richard Smith; Kenneth M Boucher; Joshua D Schiffman; Lynn B Jorde; R Lor Randall; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2012-06

6.  Fluoride exposure and childhood osteosarcoma: a case-control study.

Authors:  K H Gelberg; E F Fitzgerald; S A Hwang; R Dubrow
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

7.  International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

8.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

9.  Racial and Ethnic Differences in Sarcoma Incidence Are Independent of Census-Tract Socioeconomic Status.

Authors:  Brandon J Diessner; Brenda J Weigel; Paari Murugan; Lin Zhang; Jenny N Poynter; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-14       Impact factor: 4.254

Review 10.  Chondrosarcoma-from Molecular Pathology to Novel Therapies.

Authors:  Agnieszka E Zając; Sylwia Kopeć; Bartłomiej Szostakowski; Mateusz J Spałek; Michał Fiedorowicz; Elżbieta Bylina; Paulina Filipowicz; Anna Szumera-Ciećkiewicz; Andrzej Tysarowski; Anna M Czarnecka; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.